Mbx Biosciences
Clinical trials sponsored by Mbx Biosciences, explained in plain language.
-
New obesity drug MBX 4291 enters first human safety tests
Disease control Recruiting nowThis early-stage study tests a new drug, MBX 4291, in 124 adults with obesity (BMI 30 to under 50) to see if it is safe and how the body handles it. Participants receive either the drug or a placebo as a shot under the skin. The main goal is to track any side effects, not to meas…
Phase: PHASE1 • Sponsor: MBX Biosciences • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New shot aims to stop dangerous sugar crashes after gastric bypass
Symptom relief Recruiting nowThis study tests an experimental drug called MBX 1416 for people who have dangerously low blood sugar after weight loss surgery. Ten adults who had gastric bypass or sleeve gastrectomy at least a year ago will receive a single injection of the drug at different doses. The goal is…
Phase: PHASE2 • Sponsor: MBX Biosciences • Aim: Symptom relief
Last updated May 17, 2026 06:05 UTC